EDAP TMS S.A Total Liabilities

Latest as of June 2026: €77.77 Million EUR ≈ $90.92 Million USD

EDAP TMS S.A total liabilities. Based on the latest financial reports, EDAP TMS S.A (EDA) has total liabilities worth €77.77 Million EUR (≈ $90.92 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EDAP TMS S.A liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of EDAP TMS S.A (2016–2025)

Total liabilities of EDAP TMS S.A from 2016 to 2025. This chart illustrates how EDAP TMS S.A's total liabilities have evolved over time, based on quarterly financial data.

EDAP TMS S.A Competitors by Total Liabilities

The table below lists competitors of EDAP TMS S.A ranked by their total liabilities.

Company Country Total Liabilities
Shandong Xinhua Pharmaceutical Company Limited
F:XIN
Germany €3.47 Billion
Kustur Kusadasi Turizm Endustrisi AS
IS:KSTUR
Turkey TL27.08 Million
S&P Syndicate Public Company Limited
BK:SNP
Thailand ฿1.52 Billion
Silicon Optronics Inc
TW:3530
Taiwan NT$215.53 Million
STEEL EXCHANGE INDIA LIMITED
NSE:STEELXIND
India Rs-7.68 Billion
Dala Energi AB
ST:DE
Sweden Skr125.74 Million
Sonadezi Chau Duc Shareholding Co
VN:SZC
Vietnam ₫5.43 Trillion

Liability Composition Analysis (2016–2025)

This chart breaks down EDAP TMS S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of EDAP TMS S.A.

Liquidity & Leverage Metrics

EDAP TMS S.A Total Liabilities Ratios Explained

EDAP TMS S.A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.60 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -24.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EDAP TMS S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EDAP TMS S.A (2016–2025)

The table below shows the annual total liabilities of EDAP TMS S.A from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €59.58 Million
≈ $69.66 Million
+31.92%
2024-12-31 €45.17 Million
≈ $52.80 Million
+30.45%
2023-12-31 €34.62 Million
≈ $40.48 Million
+17.41%
2022-12-31 €29.49 Million
≈ $34.48 Million
+8.54%
2021-12-31 €27.17 Million
≈ $31.77 Million
-6.13%
2020-12-31 €28.95 Million
≈ $33.84 Million
+12.58%
2019-12-31 €25.71 Million
≈ $30.06 Million
+8.13%
2018-12-31 €23.78 Million
≈ $27.80 Million
+9.37%
2017-12-31 €21.74 Million
≈ $25.42 Million
-1.81%
2016-12-31 €22.14 Million
≈ $25.88 Million
--

About EDAP TMS S.A

F:EDA Germany Medical Distribution
Market Cap
$162.33 Million
€138.85 Million EUR
Market Cap Rank
#17967 Global
#1681 in Germany
Share Price
€3.70
Change (1 day)
-2.12%
52-Week Range
€1.69 - €5.35
All Time High
€11.70
About

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more